From the Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Parkville, Victoria, Australia; the Familial Cancer Centre, Southern Health, Victoria, Australia; the Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Australia; the Department of Medicine and Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire; the Familial Cancer Laboratory, Queensland Institute of Medical Research, Queensland, Australia; the Department of Medicine, University of Queensland, Brisbane, Queensland, Australia; the Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia; Adult Clinical Genetics, The University of Melbourne, Victoria, Australia; Ludwig Institute for Cancer Research, The Royal Melbourne Hospital, Parkville, Victoria, Australia; New Zealand Familial Gastrointestinal Cancer Registry, Auckland Hospital, Auckland, New Zealand; the Department of Gastroenterology, Middlemore Hospital, Auckland, New Zealand; the Department of Medical Genetics, Mayo Clinic, Rochester, Minnesota; the Department of Preventive Medicine, University of Southern California, Los Angeles, California; Cancer Care Ontario, Toronto, Ontario, Canada; the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; the Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; and the Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Obstet Gynecol. 2011 Apr;117(4):899-905. doi: 10.1097/AOG.0b013e3182110ea3.
To investigate the association of body mass index (BMI) in early adulthood and endometrial cancer risk for carriers of a germline mutation in a DNA mismatch repair gene.
We estimated the association between BMI at age 18-20 years and endometrial cancer risk for mismatch repair gene mutation carriers and, as a comparison group, noncarriers using 601 female carriers of a germline mutation in a mismatch repair gene (245 MLH1, 299 MSH2, 38 MSH6, and 19 PMS2) and 533 female noncarriers from the Colon Cancer Family Registry using a weighted Cox proportional hazards regression.
During 51,693 person-years of observation, we observed diagnoses of endometrial cancer for 126 carriers and eight noncarriers. For carriers, there was no evidence of an association between BMI at age 20 years and endometrial cancer (adjusted hazard ratio 0.73 per 5 kg/m²; 95% confidence interval [CI], 0.40-1.34; P=.31). For noncarriers, endometrial cancer risk increased by 74% for each 5-kg/m² increment in BMI (adjusted hazard ratio 1.74; 95% CI 1.27-2.37; P<.001). The hazard ratio for BMI and endometrial cancer for noncarriers was greater than for carriers (P=.04).
The effect of body mass on endometrial cancer risk depends on the woman's mismatch repair gene mutation carrier status, suggesting obesity-independent endometrial carcinogenesis for carriers.
II.
研究年轻时的体重指数(BMI)与携带错配修复基因种系突变者子宫内膜癌风险之间的关联。
我们使用 601 名携带错配修复基因种系突变的女性(245 名 MLH1、299 名 MSH2、38 名 MSH6 和 19 名 PMS2)和来自结肠直肠癌家族登记处的 533 名非携带者,通过加权 Cox 比例风险回归估计了 18-20 岁时 BMI 与携带错配修复基因突变者和非携带者子宫内膜癌风险之间的关联。
在 51693 人年的观察期间,我们观察到 126 名携带者和 8 名非携带者被诊断为子宫内膜癌。对于携带者,20 岁时 BMI 与子宫内膜癌之间没有关联的证据(调整后的危险比每 5kg/m² 0.73;95%置信区间 [CI],0.40-1.34;P=.31)。对于非携带者,BMI 每增加 5kg/m²,子宫内膜癌风险增加 74%(调整后的危险比 1.74;95% CI 1.27-2.37;P<.001)。非携带者的 BMI 和子宫内膜癌的危险比大于携带者(P=.04)。
体重对子宫内膜癌风险的影响取决于女性的错配修复基因突变携带者状态,这表明携带者存在与肥胖无关的子宫内膜癌发生机制。
II 级。